Best Immunotherapy Hospitals in China

Beijing GoBroad Boren Hospital provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2014, the accredited hospital is based in Beijing, China and has 200 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Shanghai GoBroad Cancer Hospital provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2016, the accredited hospital is located in Shanghai, China and operates 700 beds with advanced oncology and infusion-care facilities.

Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.

GoBroad Shanghai Zhaxin Hospital and Shanghai Liquan Hospital provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2018, the accredited hospital is based in Shanghai, China and has 300 beds supported by modern medical oncology facilities.

Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.

Choosing GoBroad Healthcare (Hematology) Guangdong Research Center for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 2018, the accredited hospital is located in Dongguan, China and operates 200 beds with modern oncology infrastructure.

Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.